NEW YORK(GenomeWeb) – Exosome Diagnostics said today that it has raised $17.6 million in a second Series B financing round.

Combined with funds from a first round, the firm said it has raised a total of $44.7 million in its Series B overall.

Participating investors in the second round included Forbion Capital Partners, NGN Capital, Arcus Ventures, Tiger Management, and CD Ventures, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.